Bayer: De-Risking Is Real, But The Pharma Cliff Keeps Me On Hold (OTCMKTS:BAYZF)
· seekingalpha.com
Bayer A.G. gets a Hold: strong Q2, Crop Science growth, Roundup risk easing, but Pharma headwinds and debt/FCF pressure remain. Click for more on BAYZF stock.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions...